Morning-evening administration time differences in digoxin kinetics in healthy young subjects

被引:21
作者
Erol, K [1 ]
Kiliç, FS [1 ]
Batu, ÖS [1 ]
Yildirim, E [1 ]
机构
[1] Osmangazi Univ, Sch Med, Dept Pharmacol, TR-26480 Meselik, Eskisehir, Turkey
关键词
chronopharmacokinetics; chronopharmacology; circadian rhythm; digoxin;
D O I
10.1081/CBI-100107519
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Digoxin, frequently used in the treatment of congestive heart failure, has a very narrow therapeutic index. We studied the differences in digoxin pharmacokinetics when ingested in the morning versus evening. A single digoxin (0.25 mg) dose was given orally to the same group of 10 diurnally active healthy (6 male and 4 female) volunteers in the morning at 08:00 and evening at 20:00 in separate experiments scheduled 2 weeks apart. Blood samples were collected at specific times for 48h after each timed dose; digoxin was determined by radioimmunoassay (RIA). Maximum plasma concentration C-max; T-max, the time to reach C-max; area under plasma concentration curve AUC; and elimination half-time T-1/2 of digoxin were determined. T-max was statistically significantly shorter (54 min) following 08:00 dosing compared to 20:00 dosing (96 min). Although the Cm was higher after morning than evening dosing, it was not significantly so. No other parameter of digoxin pharmacokinetics except Tm exhibited administration time dependency.
引用
收藏
页码:841 / 849
页数:9
相关论文
共 28 条
[1]  
Belanger PM, 1997, HANDB EXP PHARM, V125, P177
[2]  
BOUGHATTAS NA, 1990, J PHARMACOL EXP THER, V255, P672
[3]   RECENT ADVANCES IN CHRONOPHARMACOKINETICS - METHODOLOGICAL PROBLEMS [J].
BRUGUEROLLE, B ;
LEMMER, B .
LIFE SCIENCES, 1993, 52 (23) :1809-1824
[4]  
BRUGUEROLLE B, 1988, THERAPIE, V43, P251
[5]  
FUJIMARA A, 1993, LIFE SCI, V53, P395
[6]   INFLUENCE OF CLORGYLINE TREATMENT ON CHRONOPHARMACOLOGY OF FUROSEMIDE IN RATS [J].
FUJIMURA, A ;
SUDOH, T ;
SHIGA, T ;
OHASHI, K ;
EBIHARA, A .
LIFE SCIENCES, 1993, 52 (09) :819-824
[7]  
JESPERSEN CM, 1989, EUR J CLIN PHARMACOL, V37, P613
[8]  
Katzung B., 1998, BASIC CLIN PHARM, P197
[9]  
KELLY AR, 1996, GOODMAN GILMANS PHAR, P809
[10]   CIRCADIAN CHANGES IN THE PHARMACOKINETICS AND CARDIOVASCULAR EFFECTS OF ORAL PROPRANOLOL IN HEALTHY-SUBJECTS [J].
LANGNER, B ;
LEMMER, B .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 33 (06) :619-624